Kyle Jenne
Chief Commercial Officer, AKCEA THERAPEUTICS, INC.
Companies
- IONIS PHARMACEUTICALS INCEVP, Chf GL Pdt Str Ofcr Mar 13, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- IONIS PHARMACEUTICALS INC IONS23,713 shares2$1.0M at $44.05Apr 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 16, 2026Sold 4,902 shares at $75.17 of IONIS PHARMACEUTICALS INC2
- Apr 15, 2026Exercised options 12,226 shares of IONIS PHARMACEUTICALS INC2
- Mar 10, 2026Exercised options 4,675 shares at $34.69 of IONIS PHARMACEUTICALS INC3
- Mar 10, 2026Sold 16,086 shares at $76.30 of IONIS PHARMACEUTICALS INC3
- Mar 10, 2026Sold 21,191 shares at $75.50 of IONIS PHARMACEUTICALS INC3
- Mar 10, 2026Exercised options 32,602 shares at $46.10 of IONIS PHARMACEUTICALS INC3
- Jan 16, 2026Sold 1,823 shares at $75.96 of IONIS PHARMACEUTICALS INC4
- Jan 15, 2026Exercised options 7,013 shares of IONIS PHARMACEUTICALS INC4
- Apr 16, 2025Sold 3,016 shares at $28.36 of IONIS PHARMACEUTICALS INC5
- Apr 15, 2025Exercised options 12,226 shares of IONIS PHARMACEUTICALS INC5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 11, 2026
- 4SEC EDGARForm 4 filed Jan 20, 2026
- 5SEC EDGARForm 4 filed Apr 17, 2025